Andrew Shaw, MD
Anesthesiology · Cleveland, OHNPI 1619051539
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abiomed at 43.1% of the total. Reporting peaked in 2024 at $67,825 and has fallen 97.3% since, to $1,862 in 2025. Among anesthesiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $1174.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$48K
- Trevena, Inc.$13K
- Fresenius USA Marketing, Inc.$11K
- Edwards Lifesciences$9K
- AstraZeneca$7K
- Astrazeneca UK Limited$5K
- plus $18K from 12 others
What the payments were for
- Consulting fees$52,60647%
- Speaking & faculty fees$32,07029%
- Travel & lodging$22,78620%
- Food & beverage$4,1264%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 17 | $48,076 |
| Trevena, Inc. | 5 | $12,916 |
| Fresenius USA Marketing, Inc. | 9 | $11,129 |
| Edwards Lifesciences | 27 | $8,986 |
| AstraZeneca | 11 | $7,270 |
| Astrazeneca UK Limited | 2 | $5,370 |
| Chugai Pharmaceutical Co., Ltd. | 3 | $4,453 |
| Astellas Pharma Inc | 3 | $4,290 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $2,970 |
| Medela AG | 1 | $1,500 |
| Genentech, Inc. | 1 | $1,210 |
| BD | 3 | $1,195 |
| Nxstage Medical, Inc. | 6 | $1,124 |
| Pacira Pharmaceuticals Incorporated | 1 | $880 |
| Novartis | 1 | $125 |
| La Jolla Pharmaceutical Company | 2 | $47 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$47,752
- Olinvyk$12,916
- ULTOMIRIS$4,593
- NOVALUNG SYSTEM$3,174
- Invia Motion Endure$1,500
- EXPAREL$880
- NXSTAGE SYSTEM ONE$700
How this compares
$111,588 in reported general payments places this provider in the 95th percentile of 1,623 anesthesiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Cleveland
- Sabry AyadCleveland$427K
- Edwin AveryCleveland$194K
- Hesham ElsharkawyCleveland$189K
- Basem AbdelmalakCleveland$147K
- Daniel SesslerCleveland$140K
- Michael SmithCleveland$75K
- Adi CosicCleveland$57K
- Sameam ShahrestaniCleveland$57K
- Peter SchoenwaldCleveland$55K
- Mark ChmielaCleveland$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.